Inhibition of histone deacetylase activity in reduced oxygen environment enhances the osteogenesis of mouse adipose-derived stromal cells

Tissue Engineering - Part A

Volumn 15, Issue 12, 2009, Pages 3697-3707

  Xu, Yue ^a   Hammerick, Kyle E ^a   James, Aaron W ^a   Carre, Antoine L ^a   Leucht, Philipp ^a   Giaccia, Amato J ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; PROTEINS; SODIUM;

ADIPOGENESIS; ADIPOSE TISSUE; ADIPOSE-DERIVED STROMAL CELLS; BONE REGENERATION; CLINICAL APPLICATION; GROWTH INHIBITION; HDAC INHIBITORS; HISTONE DEACETYLASES; MESENCHYMAL CELLS; OSTEOGENESIS; OSTEOGENIC DIFFERENTIATION; OXYGEN TENSION; SODIUM BUTYRATE; VALPROIC ACID;

OXYGEN;

BUTYRIC ACID; HISTONE DEACETYLASE; OXYGEN; VALPROIC ACID;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE DEVELOPMENT; BONE REGENERATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; GROWTH INHIBITION; IN VIVO STUDY; MOUSE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; STROMA CELL;

EID: 72049090130     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0213     Document Type: Article

References (37)

1. Malladi, P., Xu, Y., Chiou, M., Giaccia, A.J., and Longaker, M.T. Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells. Am J Physiol 290, C1139, 2006.
2. Xu, Y., Malladi, P., Chiou, M., Bekerman, E., Giaccia, A.J., and Longaker, M.T. In vitro expansion of adipose-derived adult stromal cells in hypoxia enhances early chondrogen-esis. Tissue Eng 13, 2981, 2007.
3. Xu, Y., Malladi, P., Wagner, D.R., and Longaker, M.T. Adipose-derived mesenchymal cells as a potential cell source for skeletal regeneration. Curr Opin Mol Ther 7, 300, 2005.
4. Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., Benhaim, P., and Hedrick, M.H. Human adipose tissue is a source of multi-potent stem cells. Mol Biol Cell 13, 4279, 2002.
5. Wang, Y., Wan, C., Deng, L., Liu, X., Cao, X., Gilbert, S.R., Bouxsein, M.L., Faugere, M.C., Guldberg, R.E., Gerstenfeld, L.C., Haase, V.H., Johnson, R.S., Schipani, E., and Clemens, T.L. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117, 1616, 2007.
6. Malda, J., Klein, T.J., and Upton, Z. The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng 13, 2153, 2007.
7. Wang, D.W., Fermor, B., Gimble, J.M., Awad, H.A., and Guilak, F. Influence of oxygen on the proliferation and metabolism of adipose derived adult stem cells. J Cell Physiol 204, 184, 2005.
8. Papandreou, I., Cairns, R.A., Fontana, L., Lim, A.L., and Denko, N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3, 187, 2006.
9. Papandreou, I., Powell, A., Lim, A.L., and Denko, N. Cellular reaction to hypoxia: sensing and responding to an adverse environment. Mutat Res 569, 87, 2005.
10. Wan, C., Gilbert, S.R., Wang, Y., Cao, X., Shen, X., Ramaswamy, G., Jacobsen, K.A., Alaql, Z.S., Eberhardt, A.W., Gerstenfeld, L.C., Einhorn, T.A., Deng, L., and Clemens, T.L. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci USA 105, 686, 2008.
11. D'Ippolito, G., Diabira, S., Howard, G.A., Roos, B.A., and Schiller, P.C. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone 39, 513, 2006.
12. Utting, J.C., Robins, S.P., Brandao-Burch, A., Orriss, I.R., Behar, J., and Arnett, T.R. Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp Cell Res 312, 1693, 2006.
13. Potier, E., Ferreira, E., Andriamanalijaona, R., Pujol, J.P., Oudina, K., Logeart-Avramoglou, D., and Petite, H. Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone 40, 1078, 2007.
14. Shahbazian, M.D., and Grunstein, M. Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 76, 75, 2007.
15. Eilertsen, K.J., Floyd, Z., and Gimble, J.M. The epigenetics of adult (somatic) stem cells. Crit Rev Eukaryot Gene Expr 18, 189, 2008.
16. Mottet, D., and Castronovo, V. Histone deacetylases: target enzymes for cancer therapy. Clin Exp Metastasis 25, 183, 2008.
17. Young, D.A., Lakey, R.L., Pennington, C.J., Jones, D., Kevorkian, L., Edwards, D.R., Cawston, T.E., and Clark, I.M. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage re-sorption. Arthritis Res Ther 7, R503, 2005.
18. Cho, H.H., Park, H.T., Kim, Y.J., Bae, Y.C., Suh, K.T., and Jung, J.S. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors. J Cell Biochem 96, 533, 2005.
19. Vega, R.B., Matsuda, K., Oh, J., Barbosa, A.C., Yang, X., Meadows, E., McAnally, J., Pomajzl, C., Shelton, J.M., Richardson, J.A., Karsenty, G., and Olson, E.N. Histone deacetylase 4 controls chondrocyte hypertrophy during ske-letogenesis. Cell 119, 555, 2004.
20. Lee, H.W., Suh, J.H., Kim, A.Y., Lee, Y.S., Park, S.Y., and Kim, J.B. Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation. Mol Endocrinol 20, 2432, 2006.
21. Jensen, E.D., Schroeder, T.M., Bailey, J., Gopalakrishnan, R., and Westendorf, J.J. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner. J Bone Miner Res 23, 361, 2008.
22. Schroeder, T.M., Kahler, R.A., Li, X., and Westendorf, J.J. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J Biol Chem 279, 41998, 2004.
23. Lee, S.H., Kim, J., Kim, W.H., and Lee, Y.M. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 28, 184, 2009.
24. Pluemsampant, S., Safronova, O.S., Nakahama, K., and Morita, I. Protein kinase CK2 is a key activator of histone deacetylase in hypoxia-associated tumors. Int J Cancer 122, 333, 2008.
25. Xu, Y., Malladi, P., Zhou, D., and Longaker, M.T. Molecular and cellular characterization of mouse calvarial osteoblasts derived from neural crest and paraxial mesoderm. Plast Reconstr Surg 120, 1783, 2007.
26. James, A.W., Xu, Y., Wang, R., and Longaker, M.T. Proliferation, osteogenic differentiation, and fgf-2 modulation of posterofrontal/sagittal suture-derived mesenchymal cells in vitro. Plast Reconstr Surg 122, 53, 2008.
27. Malladi, P., Xu, Y., Chiou, M., Giaccia, A.J., and Longaker, M.T. Hypoxia inducible factor-1alpha deficiency affects chondrogenesis of adipose-derived adult stromal cells. Tissue Eng 13, 1159, 2007.
28. Leucht, P., Kim, J.B., and Helms, J.A. Beta-catenin-dependent Wnt signaling in mandibular bone regeneration. J Bone Joint Surg 90 Suppl 1, 3, 2008.
29. Kim, J.B., Leucht, P., Lam, K., Luppen, C., Ten Berge, D., Nusse, R., and Helms, J.A. Bone regeneration is regulated by wnt signaling. J Bone Miner Res 22, 1913, 2007.
30. Gimble, J.M., and Guilak, F. Differentiation potential of adipose derived adult stem (ADAS) cells. Curr Top Dev Biol 58, 137, 2003.
31. Salim, A., Nacamuli, R.P., Morgan, E.F., Giaccia, A.J., and Longaker, M.T. Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteo-blasts. J Biol Chem 279, 40007, 2004.
32. Fehrer, C., Brunauer, R., Laschober, G., Unterluggauer, H., Reitinger, S., Kloss, F., Gully, C., Gassner, R., and Lepper-dinger, G. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging cell 6, 745, 2007.
33. Jensen, E.D., Nair, A.K., and Westendorf, J.J. Histone dea-cetylase co-repressor complex control of Runx2 and bone formation. Crit Rev Eukaryot Gene Expr 17, 187, 2007.
34. de Boer, J., Licht, R., Bongers, M., van der Klundert, T., Arends, R., and van Blitterswijk, C. Inhibition of histone acetylation as a tool in bone tissue engineering. Tissue Eng 12, 2927, 2006.
35. Schroeder, T.M., and Westendorf, J.J. Histone deacetylase inhibitors promote osteoblast maturation. J Bone Miner Res 20, 2254, 2005.
36. Floyd, Z.E., Kilroy, G., Wu, X., and Gimble, J.M. Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions. J Cell Biochem 101, 1545, 2007.
37. Irwin, R., LaPres, J.J., Kinser, S., and McCabe, L.R. Prolyl-hydroxylase inhibition and HIF activation in osteoblasts promotes an adipocytic phenotype. J Cell Biochem 100, 762, 2007.